Telomir Pharmaceuticals

Telomir Pharmaceuticals

Telomere-based therapies targeting age-related diseases by enhancing DNA protection and cell renewal.

HQ location
Tampa, United States
Launch date
Employees
Market cap
$46.7m
Enterprise value
$47m
Share price
$1.25 TELO
Authorizing premium user...